Virtus LifeSci Biotech Clinical Trials ETF (BBC)Health | Exchange Traded Fund | NYSEArca
47.42 USD
+1.04
(2.234%)
⇧
(April 17, 2026, 3:59 p.m.
EDT)
After hours: 47.42 Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ★★★☆☆ |
Hot Take | April 11, 2026, 1:20 p.m. EDT
BBC is currently in a volatile phase with recent price fluctuations and mixed options activity. While it has reached a 52-week high, the recent dip and low volume suggest caution. The dividend yield is decent, but the inconsistent payout history raises concerns. Short-term traders might consider buying calls near the ATM strike, while long-term investors should be cautious due to the uncertain fundamentals and recent volatility. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.036346 |
| AutoTheta | 0.037816 |
| MSTL | 0.039008 |
| AutoARIMA | 0.065654 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 70% |
| H-stat | 1.28 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.298 |
| Excess Kurtosis | 0.43 |
As of April 11, 2026, 1:20 p.m. EDT: Options speculators are showing mixed signals. For calls, the ATM strike at 42.0 has high IV and OI, suggesting some confidence in the stock reaching this level. However, the recent volatility and the presence of puts with high IV at strikes like 40.0 and 38.0 indicate potential bearish sentiment. The overall options activity suggests a cautious outlook with a focus on short-term price movements rather than long-term gains.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 1.63% | 1.63% | 1.00% | 0.60% |
| Date | Dividend | Yield % |
|---|---|---|
| 2025-12-22 | 0.655 | 1.630164 |
| 2024-12-20 | 0.240 | 1.003165 |
| 2023-12-20 | 0.082 | 0.378677 |
| 2017-12-20 | 0.297 | 1.117623 |
| 2015-12-21 | 0.147 | 0.525466 |
| Attribute | Value |
|---|---|
| All Time High | 62.6 |
| All Time Low | 13.42 |
| Ask | 47.8 |
| Ask Size | 300 |
| Average Daily Volume10 Day | 15,360 |
| Average Daily Volume3 Month | 19,555 |
| Average Volume | 19,555 |
| Average Volume10Days | 15,360 |
| Beta3 Year | 1.4 |
| Bid | 45.37 |
| Bid Size | 300 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 47.81 |
| Day Low | 46.84 |
| Dividend Date | 1,514,332,800 |
| Dividend Yield | 1.57 |
| Esg Populated | 0 |
| Exchange | PCX |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 41.74712 |
| Fifty Day Average Change | 5.6728783 |
| Fifty Day Average Change Percent | 0.1358867 |
| Fifty Two Week Change Percent | 170.1456 |
| Fifty Two Week High | 47.81 |
| Fifty Two Week High Change | -0.3900032 |
| Fifty Two Week High Change Percent | -0.008157356 |
| Fifty Two Week Low | 16.6 |
| Fifty Two Week Low Change | 30.819998 |
| Fifty Two Week Low Change Percent | 1.8566263 |
| Fifty Two Week Range | 16.6 - 47.81 |
| First Trade Date Milliseconds | 1,418,826,600,000 |
| Five Year Average Return | -0.0035378998 |
| Full Exchange Name | NYSEArca |
| Fund Family | Virtus |
| Fund Inception Date | 1,418,688,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. |
| Long Name | Virtus LifeSci Biotech Clinical Trials ETF |
| Market | us_market |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_274653436 |
| Nav Price | 46.24496 |
| Net Assets | 35,456,444.0 |
| Net Expense Ratio | 0.65 |
| Open | 47.0 |
| Phone | (212) 593-4383 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 47.42 |
| Post Market Time | 1,776,462,481 |
| Previous Close | 46.3839 |
| Price Hint | 2 |
| Quote Source Name | Delayed Quote |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | 1.0361 |
| Regular Market Change Percent | 2.23375 |
| Regular Market Day High | 47.81 |
| Regular Market Day Low | 46.84 |
| Regular Market Day Range | 46.84 - 47.81 |
| Regular Market Open | 47.0 |
| Regular Market Previous Close | 46.3839 |
| Regular Market Price | 47.42 |
| Regular Market Time | 1,776,455,961 |
| Regular Market Volume | 28,055 |
| Short Name | Virtus Biotech Clinical Trials |
| Source Interval | 15 |
| Symbol | BBC |
| Three Year Average Return | 0.29634002 |
| Total Assets | 35,456,444 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 7.83771 |
| Trailing Three Month Returns | 7.83771 |
| Triggerable | 1 |
| Two Hundred Day Average | 33.074017 |
| Two Hundred Day Average Change | 14.345982 |
| Two Hundred Day Average Change Percent | 0.43375385 |
| Type Disp | ETF |
| Volume | 28,055 |
| Yield | 0.015700001 |
| Ytd Return | 7.83771 |